NCT05700006 2026-03-05
BETA
University of Michigan
Completed
Clinical Trials
10 trialsNCT06495164 2025-11-25
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
Pfizer
Active not recruiting
NCT06086340 2025-11-18
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
Pfizer
Completed
NCT05361655 2024-06-07
Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor
Pfizer
Completed
NCT05801705 2023-05-18
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT00111241 2018-12-14
Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors
Monash University
Completed
NCT00755313 2017-11-24
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
University of California, San Francisco
Completed
NCT01298362 2016-09-20
POCHARBI
Hellenic Breast Surgeons Society
Completed
NCT00784888 2012-03-15
TAMARA
Pfizer
Completed
NCT01311037 2011-12-13
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
King Faisal Specialist Hospital & Research Center
Unknown